Login
Toggle navigation
Videos
Categories
Trending
Arun Jain, Chairman and CEO of Polaris Financial Technology Ltd., shares his views on ...
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Arun Jain, Chairman and CEO of Polaris Financial Technology Ltd
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Unlocking Value in Junior Mining: Insights from John Black of Regulus Resources Inc. | John Black - CEO & Director, Regulus Resources Inc.
00:10:00
Overview of Provider Relief Act for Dentists and Healthcare Practices
00:10:00
Josh Sapan on the Evolution of Television: Content is Still King | Josh Sapan, CEO, AMC Networks Inc.
00:10:00
Belive it or not techonology can save time to make any decesions|Chris Wake,Founder, Atypical Ventures
00:00:00
Richard O. White, M.D.Pediatrician
00:10:00
Rafaela Resources: Driving Forward with Critical Metals Focus
00:10:00
Navigating Financial Complexity: The Vital Role of Human Advisors | Dave Butler, CEO , Dimensional Fund Advisors.
00:10:00
Tim Gabrick on ISO Energy's Diversification and Market Position
00:00:00
Isaac Kohane, MD, PhD Chair of the Department of Biomedical Informatics, Harvard Medical School | Artificial Intelligence and NEJM AI
00:10:00
Patriot Lithium’s Gorman Project Yields Promising Results: CEO Nicholas Vickery Shares Insights | Nick Vickery ,CEO , Patriot Lithium Ltd.
00:10:00
"Exploring Careers in Asset Management: An Informative Webinar in Partnership with State Street Global Advisors Featuring Insights from Industry Experts"
00:10:00
Chris Doros on E3 Lithium’s Growth, Industry Challenges, and the EV Transition